Tim Carleton is backing the Aussie dream all the way

Carleton’s conviction will be on full display on Friday when he makes his third appearance at the Sohn Hearts & Minds Conference, where stock-pickers share their best ideas in the name of medical research.

Tim Carleton is backing the Aussie dream all the way

November 14, 2022
Carleton’s conviction will be on full display on Friday when he makes his third appearance at the Sohn Hearts & Minds Conference, where stock-pickers share their best ideas in the name of medical research.
Read Transcript

If Tim Carleton from Auscap Asset Management has conviction about one thing, it’s that our home country bias should be embraced, not managed.

“Don’t get bearish, Australia,” he tells The Australian Financial Review. “This is the best spot to invest over our lifetimes. I have no doubt about that.”

Carleton’s conviction will be on full display on Friday, when he makes his third appearance at the annual Sohn Hearts & Minds Investment Leaders Conference, where stock-pickers share their best ideas in the name of medical research.

After a dramatic year in bond and stock markets that has weighed on the $550 million listed investment company, which executes the best ideas of conference presenters, Carleton says it’s a great idea to buy into both the ASX listed Sohn Hearts & Minds fund (known as HM1) at its double-digit discount to asset value, and a ticket to the Hobart event.

“There’s a fair bit of value around domestically and internationally,” he says.

Presenters keep their tips close to their chests. But if the portfolio of Carleton’s Auscap Asset Management is any guide, it’s likely to be a bet on the Lucky Country.

“Over the last 100 years Australia has performed better from the stock market perspective than the US, and it’s been an extraordinary 100 years for the US,” says Carleton.

“Yet, on a go-forward basis, you’d have to say there are more tailwinds for this economy than there are for the US.”

Time to go shopping

In his previous speaking gigs at Sohn Hearts & Minds, Carleton pitched Macquarie Group in 2018 and retailer JB Hi-Fi in 2019. The out-of-favour Australian retail sector is where he believes good money can be made.

“Opportunities are in sectors that the market is pessimistic about based on what Howard Marks would consider to be a level-one observation: interest rates are going up, therefore, disposable in households is going down, and therefore discretionary expenditure gets hit.

“We think you need to look a little deeper and analyse what’s actually going on in individual companies. If you do that, there’s a lot of compelling opportunities.”

About a third of Auscap’s portfolio is invested in consumer discretionary stocks, according to its November update. That still includes JB Hi-Fi, along with Lovisa, Premier Investments, and Nick Scali.

Carleton says the disconnect is due to the market under-estimating how resilient Australian household balance sheets are, but there’s also an element of mis-categorisation when it comes to the retail category.

Specifically, the goods that listed discretionary retailers sell have become more like essential items over the last 20 years, a point he says is underappreciated by the market. That includes electronics like mobile phones and laptop computers.

“You tell me which person could do without either of those products in their house for even a single day. I would suggest to you that these are among the least discretionary items.”

The migration of electronics from discretionary to staples is partly due to our increasingly connected world, but also, two decades of deflation as they’ve become a smaller part of the household budget.

While Carleton is a natural stock-picker, he devotes extensive time and effort to studying the macro environment, and 2022 has been all about the macro, as the war on inflation drives the direction of asset prices.

The peak is near

In July, Auscap wrote a detailed 22-page update examining the macro environment to determine if and when inflation was likely to peak, and what that would mean for shares.

It concluded that it was “reasonable to expect that many of the inflationary pressures that are currently driving global inflation are likely to abate over the coming year”.

So, when the S&P/ASX 200 surged almost 3 per cent on Friday on a high – but lower than expected – US inflation result, Carleton was feeling good about how he had positioned his portfolio.

If history is any guide, he says, sharemarkets bottom when inflation peaks. That’s been the case in five of the last six episodes, explaining the market’s spectacular end to last week.

The signs that inflation may have peaked in the US, and that it will peak some time next year, are there. He notes that global shipping rates are down 73 per cent from their peak in September 2021.

“They were a large part of the reason inflation picked up for different categories. Anything that is imported into our country has the shipping cost associated with it.

“We knew this firsthand because of Nick Scali. They had told us that shipping costs had gone up so much that for some items they were representing up to a third of the cost of the product, which is pretty extraordinary, given it’s selling big ticket items.”

Inflation, Carleton says, is actually positive for the most efficient, well-run retailers. Since all operators experience the same cost input inflation, the less efficient retailers are under more pressure to increase prices.

That, he says, allows leaner ones to lower prices to capture market share, or to simply earn higher margins because their cost base is lower than their peers.

“In that environment, you actually want to own the efficient retailers because they will probably deliver results well ahead of expectations.”

Auscap’s origin story

Carleton founded Auscap in 2013 with his former Goldman Sachs trading colleague Matt Parker.

It has grown into one of the most well-regarded boutique Australian equities managers, and has delivered annualised returns since inception of 15.3 per cent. compared to 8.9 per cent for the broader All Ordinaries index.

The fund is down 12.4 per cent over the calendar year, but up 17.3 per cent so far this financial year.

Carleton says it’s been a period driven by sentiment rather than outcomes.

“We’ve seen companies give pretty significant upgrades and trade down, because the expectation is that the bearish news will come next time.”

But he’s comfortable with how Auscap’s companies are performing in the portfolio, and he’s been enjoying hitting the road, visiting operations around the country.

Which brings us back to Australia, and why Carleton believes it will be an investors’ paradise for years.

The reasons he lists are favourable demographics, a functioning democracy with rule of law, an abundance of soft and hard commodities, and all the ingredients to be at the centre of a green energy revolution.

“If you think about the big picture issues that are going to determine the path for Australia over the next 50 years, they all look fairly positive from our perspective,” says Carleton.

“The companies that operate here and the people who live here will be natural beneficiaries.”

The Australian Financial Review is a media partner of sohnheartsandminds.com.au

This article was originally posted by The Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

If Tim Carleton from Auscap Asset Management has conviction about one thing, it’s that our home country bias should be embraced, not managed.

“Don’t get bearish, Australia,” he tells The Australian Financial Review. “This is the best spot to invest over our lifetimes. I have no doubt about that.”

Carleton’s conviction will be on full display on Friday, when he makes his third appearance at the annual Sohn Hearts & Minds Investment Leaders Conference, where stock-pickers share their best ideas in the name of medical research.

After a dramatic year in bond and stock markets that has weighed on the $550 million listed investment company, which executes the best ideas of conference presenters, Carleton says it’s a great idea to buy into both the ASX listed Sohn Hearts & Minds fund (known as HM1) at its double-digit discount to asset value, and a ticket to the Hobart event.

“There’s a fair bit of value around domestically and internationally,” he says.

Presenters keep their tips close to their chests. But if the portfolio of Carleton’s Auscap Asset Management is any guide, it’s likely to be a bet on the Lucky Country.

“Over the last 100 years Australia has performed better from the stock market perspective than the US, and it’s been an extraordinary 100 years for the US,” says Carleton.

“Yet, on a go-forward basis, you’d have to say there are more tailwinds for this economy than there are for the US.”

Time to go shopping

In his previous speaking gigs at Sohn Hearts & Minds, Carleton pitched Macquarie Group in 2018 and retailer JB Hi-Fi in 2019. The out-of-favour Australian retail sector is where he believes good money can be made.

“Opportunities are in sectors that the market is pessimistic about based on what Howard Marks would consider to be a level-one observation: interest rates are going up, therefore, disposable in households is going down, and therefore discretionary expenditure gets hit.

“We think you need to look a little deeper and analyse what’s actually going on in individual companies. If you do that, there’s a lot of compelling opportunities.”

About a third of Auscap’s portfolio is invested in consumer discretionary stocks, according to its November update. That still includes JB Hi-Fi, along with Lovisa, Premier Investments, and Nick Scali.

Carleton says the disconnect is due to the market under-estimating how resilient Australian household balance sheets are, but there’s also an element of mis-categorisation when it comes to the retail category.

Specifically, the goods that listed discretionary retailers sell have become more like essential items over the last 20 years, a point he says is underappreciated by the market. That includes electronics like mobile phones and laptop computers.

“You tell me which person could do without either of those products in their house for even a single day. I would suggest to you that these are among the least discretionary items.”

The migration of electronics from discretionary to staples is partly due to our increasingly connected world, but also, two decades of deflation as they’ve become a smaller part of the household budget.

While Carleton is a natural stock-picker, he devotes extensive time and effort to studying the macro environment, and 2022 has been all about the macro, as the war on inflation drives the direction of asset prices.

The peak is near

In July, Auscap wrote a detailed 22-page update examining the macro environment to determine if and when inflation was likely to peak, and what that would mean for shares.

It concluded that it was “reasonable to expect that many of the inflationary pressures that are currently driving global inflation are likely to abate over the coming year”.

So, when the S&P/ASX 200 surged almost 3 per cent on Friday on a high – but lower than expected – US inflation result, Carleton was feeling good about how he had positioned his portfolio.

If history is any guide, he says, sharemarkets bottom when inflation peaks. That’s been the case in five of the last six episodes, explaining the market’s spectacular end to last week.

The signs that inflation may have peaked in the US, and that it will peak some time next year, are there. He notes that global shipping rates are down 73 per cent from their peak in September 2021.

“They were a large part of the reason inflation picked up for different categories. Anything that is imported into our country has the shipping cost associated with it.

“We knew this firsthand because of Nick Scali. They had told us that shipping costs had gone up so much that for some items they were representing up to a third of the cost of the product, which is pretty extraordinary, given it’s selling big ticket items.”

Inflation, Carleton says, is actually positive for the most efficient, well-run retailers. Since all operators experience the same cost input inflation, the less efficient retailers are under more pressure to increase prices.

That, he says, allows leaner ones to lower prices to capture market share, or to simply earn higher margins because their cost base is lower than their peers.

“In that environment, you actually want to own the efficient retailers because they will probably deliver results well ahead of expectations.”

Auscap’s origin story

Carleton founded Auscap in 2013 with his former Goldman Sachs trading colleague Matt Parker.

It has grown into one of the most well-regarded boutique Australian equities managers, and has delivered annualised returns since inception of 15.3 per cent. compared to 8.9 per cent for the broader All Ordinaries index.

The fund is down 12.4 per cent over the calendar year, but up 17.3 per cent so far this financial year.

Carleton says it’s been a period driven by sentiment rather than outcomes.

“We’ve seen companies give pretty significant upgrades and trade down, because the expectation is that the bearish news will come next time.”

But he’s comfortable with how Auscap’s companies are performing in the portfolio, and he’s been enjoying hitting the road, visiting operations around the country.

Which brings us back to Australia, and why Carleton believes it will be an investors’ paradise for years.

The reasons he lists are favourable demographics, a functioning democracy with rule of law, an abundance of soft and hard commodities, and all the ingredients to be at the centre of a green energy revolution.

“If you think about the big picture issues that are going to determine the path for Australia over the next 50 years, they all look fairly positive from our perspective,” says Carleton.

“The companies that operate here and the people who live here will be natural beneficiaries.”

The Australian Financial Review is a media partner of sohnheartsandminds.com.au

This article was originally posted by The Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by Australian Financial Review, published on Nov 14, 2022. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Eminence Capital founder Ricky Sandler in Sydney. Picture: John Feder‍Eminence Capital founder Ricky Sandler in Sydney. Picture: John Feder‍Eminence Capital founder Ricky Sandler in Sydney. Picture: John Feder‍Eminence Capital founder Ricky Sandler in Sydney. Picture: John Feder‍
November 6, 2024

Why this New York hedge fund manager sees opportunity in European stocks

Influential New York-hedge fund manager Ricky Sandler will turn to Europe for his next stock pick.

Read More
Vihari Ross of Antipodes. Picture: Louie DouvisVihari Ross of Antipodes. Picture: Louie DouvisVihari Ross of Antipodes. Picture: Louie DouvisVihari Ross of Antipodes. Picture: Louie Douvis
November 5, 2024

Antipodes’ Ross says short-term wealth hinges on US election

The portfolio manager says defensive stocks pose a bigger risk than the magnificent seven for investors that are overexposed to the American sharemarket.

Read More
Antipodes Partners portfolio manager Vihari Ross: ‘We ask where the overvaluation is and where the opportunity is.’ Picture: John FederAntipodes Partners portfolio manager Vihari Ross: ‘We ask where the overvaluation is and where the opportunity is.’ Picture: John FederAntipodes Partners portfolio manager Vihari Ross: ‘We ask where the overvaluation is and where the opportunity is.’ Picture: John FederAntipodes Partners portfolio manager Vihari Ross: ‘We ask where the overvaluation is and where the opportunity is.’ Picture: John Feder
November 5, 2024

Concentration risk key for investors: Antipodes Partners’ Vihari Ross

The concentration risk in global stock indexes that has built up during the strong rise over the past year must now be a key consideration for global investors, according to Vihari Ross.

Read More
JO Hambro Asset Management senior portfolio manager Samir Mehta.JO Hambro Asset Management senior portfolio manager Samir Mehta.JO Hambro Asset Management senior portfolio manager Samir Mehta.JO Hambro Asset Management senior portfolio manager Samir Mehta.
November 5, 2024

The fundie betting big on China – with help from AI

Mr Mehta is sticking to his well-worn strategy: he’s hunting for companies across Asia that aren’t battling intense competition and have management teams focused on costs, cash generation and high payouts to shareholders.

Read More
Beeneet Kothari is ready to shock the Sohn Hearts & Minds event.Beeneet Kothari is ready to shock the Sohn Hearts & Minds event.Beeneet Kothari is ready to shock the Sohn Hearts & Minds event.Beeneet Kothari is ready to shock the Sohn Hearts & Minds event.
October 29, 2024

Why this fundie wants you to ‘wince’ at his stock picks

When fund managers come to pitch their favourite stock at the annual Sohn Hearts & Minds conference, there are two ways they can go: they can play it safe, or they can take a risk and shock the room.

Read More
October 27, 2024

IFM Investors’ Rikki Bannan backs small cap investments to rebound after mixed performance

IFM Investors executive director Rikki Bannan believes this year could be a good one to invest in some select small cap stocks.

Read More
October 22, 2024

Meet the 2024 Conference Managers

Following a global search, the Conference Fund Manager Selection Committee is pleased to share eleven new managers for 2024.

Read More
October 21, 2024

Chris Kourtis is on a winning streak. Here’s his next ASX pick

Chris Kourtis of Ellerston Capital thinks he’s found another winner and thinks it’s the last chance to have a bite at the cherry before the strategy plays out.

Read More
Ellerston Capital portfolio manager Chris Kourtis. Picture: Britta CampionEllerston Capital portfolio manager Chris Kourtis. Picture: Britta CampionEllerston Capital portfolio manager Chris Kourtis. Picture: Britta CampionEllerston Capital portfolio manager Chris Kourtis. Picture: Britta Campion
October 21, 2024

Why Ellerston Capital’s Chris Kourtis plans to back a ‘hated’ stock

Chris Kourtis of Ellerston Capital plans to tip one of the “most hated” stocks in Australia when he presents at the 2024 Sohn Hearts & Minds Conference.

Read More
 ‘We’re riding a wave which started (with) the first silicon chips,’ Alex Pollak says. Picture: Britta Campion ‘We’re riding a wave which started (with) the first silicon chips,’ Alex Pollak says. Picture: Britta Campion ‘We’re riding a wave which started (with) the first silicon chips,’ Alex Pollak says. Picture: Britta Campion ‘We’re riding a wave which started (with) the first silicon chips,’ Alex Pollak says. Picture: Britta Campion
October 14, 2024

Alex Pollak champions rewards of disruptive investment

Alex Pollak’s funds management company Loftus Peak rode the Nvidia wave and he is now looking at more opportunities in disruptive industry stocks.

Read More
October 8, 2024

Sumit Gautam - Why AI won't deliver in 2025 | Scalar Gauge

Sumit Gautam is the Founder of Scalar Gauge and speaks with Equity Mates ahead of his appearance at the Sohn Hearts & Minds conference.

Read More
September 30, 2024

Missed out on Nvidia and Ozempic? This fundie says it’s never too late

Northcape Capital’s Fleur Wright is still kicking herself for not owning market darlings Nvidia and Novo Nordisk, the maker of the weight loss wonder drug Ozempic, before shares of those companies rocketed in 2023.

Read More
September 23, 2024

Scalar Gauge Fund founder Sumit Gautam cautious about over-hyped AI

Tech investor Sumit Gautam carefully avoids the word bubble when describing the investor frenzy surrounding the rise of artificial intelligence, but warns there are dangers of getting caught up in the hype.

Read More
September 9, 2024

The Wellcome Trust’s Nick Moakes made a 100-year bet. It’s paying off

Chief Investment Officer, Nick Moakes raised almost $3 billion at ultra-low rates. Sometimes the long view can be the most profitable.

Read More
Wellcome Trust chief investment officer Nicholas Moakes. Picture: Steven PocockWellcome Trust chief investment officer Nicholas Moakes. Picture: Steven PocockWellcome Trust chief investment officer Nicholas Moakes. Picture: Steven PocockWellcome Trust chief investment officer Nicholas Moakes. Picture: Steven Pocock
September 5, 2024

Honesty the only policy that matters, says Wellcome Trust’s Nicholas Moakes

The chief investment officer of the London-based $71bn Wellcome Trust, Nick Moakes, has a simple rule for the trust’s investment team: “Never invest with anyone who is or has been or should have been in prison.”

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.